LOAMS
RPRX icon

Lombard Odier Asset Management (Switzerland)’s Royalty Pharma RPRX Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Hold
7,133
– – 0.01% 391
2026
Q1 		$342K Buy
+7,133
New +$312K 0.01% 400
2025
Q4 		– Sell
-12,333
Closed -$435K – 309
2025
Q3 		$435K Buy
+12,333
New +$446K 0.02% 263

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s RPRX Position: Q2 2026 in Review

Lombard Odier Asset Management (Switzerland) held its Royalty Pharma (RPRX) position steady in Q2 2026 at 7,133 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #391.

Lombard Odier Asset Management (Switzerland) first reported a position in RPRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $435K in Q3 2025. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Lombard Odier Asset Management (Switzerland) held 7,133 shares of Royalty Pharma worth $400K as of Q2 2026.
  • Lombard Odier Asset Management (Switzerland) left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up 0.01% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q2 2026, its #391 holding.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Royalty Pharma in Q3 2025 and has held it in 3 quarters since.
  • Lombard Odier Asset Management (Switzerland)'s Royalty Pharma position peaked at $435K in Q3 2025.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2026, filed 14 Aug 2026.